Flexible Nucleoside Antiviral Therapeutics Dual Inhibitors Against SARS, MERS, SARS CoV-2 and Future Emerging Coronavirus Infections

Principal Investigator: Luis Schang

Baker Institute for Animal Health
Sponsor: University Of Maryland Baltimore
Grant Number: UNIV0063-01
Title: Flexible Nucleoside Antiviral Therapeutics Dual Inhibitors Against SARS, MERS, SARS CoV-2 and Future Emerging Coronavirus Infections
Project Amount: $48,901
Project Period: June 2020 to November 2020